BPA
YARW

Beacon Pointe Advisors’s Yarrow Bioscience YARW Stock Holding History

Beacon Pointe Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-82
Closed -$11.1K – 1198
2022
Q4 		$11.1K Sell
82
-1
-1% -$200 ﹤0.01% 1057
2022
Q3 		$17K Hold
83
– – ﹤0.01% 990
2022
Q2 		$28K Hold
83
– – ﹤0.01% 1031
2022
Q1 		$49K Buy
+83
New +$49.3K ﹤0.01% 1174
2021
Q4 		– Sell
-18
Closed -$22K – 1014
2021
Q3 		$22K Buy
18
+4
+29% +$7.76K ﹤0.01% 893
2021
Q2 		$44K Hold
14
– – ﹤0.01% 823
2021
Q1 		$83K Buy
14
+1
+8% +$7.25K 0.01% 521
2020
Q4 		$72K Sell
13
-2
-13% -$12.6K ﹤0.01% 498
2020
Q3 		$90K Sell
15
-12
-44% -$70K 0.01% 392
2020
Q2 		$166K Buy
+27
New +$183K 0.02% 383

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Beacon Pointe Advisors's YARW Position: Q1 2023 in Review

Beacon Pointe Advisors sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 82 shares — an estimated $11.1K sold.

Beacon Pointe Advisors first reported a position in YARW in Q2 2020 and held it in 10 quarters. The position peaked at $166K in Q2 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Beacon Pointe Advisors reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 82 Yarrow Bioscience shares in Q1 2023, an estimated $11.1K.
  • Beacon Pointe Advisors first reported a position in Yarrow Bioscience in Q2 2020 and held it in 10 quarters.
  • Beacon Pointe Advisors's Yarrow Bioscience position peaked at $166K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Beacon Pointe Advisors's 13F filing for Q1 2023, filed 12 May 2023.